Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|June 9, 2021
Primary Renal LeiomyosarcomaYunshen Ding, Changyi QuanDiscover Oncology|September 30, 2025
Identification of KIF14 as a ferroptosis biomarker for predicting the prognosis and immunotherapy efficacy of bladder cancerXiaocheng Ma, Changyi QuanJournal of Cellular Biochemistry|March 11, 2005
Genetic and epigenetic aspects of bladder cancerWun-Jae Kim, Changyi QuanFrontiers in Oncology|May 1, 2023
Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort studyYupeng Cui, Youyi Lu, Jitao Wu, et al.Translational Cancer Research|September 12, 2022
Primary teratoma of the adrenal gland: a case reportXiaocheng Ma, Zongsu Zhang, Simeng Wen, et al.International Urology and Nephrology|February 1, 2025
Prognostic factors in T1 high-grade urothelial carcinoma of the bladder with lymphovascular invasion: a retrospective cohort studyYajun Li, Xiaoyu Sun, Yue Wang, et al.Journal of Endourology|October 6, 2011
Laparoscopic Madigan prostatectomyChangyi Quan, Wenliang Chang, Jing Chen, et al.Cancer Reports (Hoboken, N.J.)|June 22, 2023
Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymalHaotian Wei, Zhaochen Li, Yang Zhao, et al.Cancer Letters|December 11, 2012
HoxB3 promotes prostate cancer cell progression by transactivating CDCA3Jing Chen, Shimiao Zhu, Ning Jiang, et al.Experimental Cell Research|June 2, 2026
DMBX1 facilitates tumor progression via triggering epithelial-mesenchymal transition and cancer cell stemness mediated by DMBX1/PAX2/SOX5 axis in prostate cancer cellsZhaochen Li, Kailai Chen, Zhenming Pan, et al.Pageof 4